| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K58730230 | CTRPv2 | pan-cancer | AAC | -0.035 | 0.6 |
| mRNA | BRD-K09344309 | CTRPv2 | pan-cancer | AAC | -0.037 | 0.6 |
| mRNA | QS11 | CTRPv2 | pan-cancer | AAC | -0.035 | 0.7 |
| mRNA | PRL-3 Inhibitor I | CTRPv2 | pan-cancer | AAC | 0.019 | 0.7 |
| mRNA | Bexarotene | CTRPv2 | pan-cancer | AAC | -0.017 | 0.7 |
| mRNA | selumetinib:navitoclax (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.017 | 0.7 |
| mRNA | Bleomycin | CTRPv2 | pan-cancer | AAC | 0.017 | 0.7 |
| mRNA | MLN4924 | CTRPv2 | pan-cancer | AAC | 0.015 | 0.7 |
| mRNA | BEC | CTRPv2 | pan-cancer | AAC | 0.031 | 0.7 |
| mRNA | Sildenafil | CTRPv2 | pan-cancer | AAC | 0.017 | 0.7 |